MMP9 and coronary artery disorder: Therefore, MMP-9 is also suggested as a potential biomarker for assessing atherosclerotic plaque stability and predicting future cardiovascular and cerebrovascular events [47], serving as an early indicator of disease severity and a potential risk factor for complications in CAD patients [36].